Clinical Trial Update: Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy [NA]

View source ↗

Summary

Clinical trial investigating intravitreal bevacizumab for proliferative diabetic retinopathy has completed (NCT00423059).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Proliferative Diabetic Retinopathy

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Yonsei University | Conditions: Diabetic Retinopathy | NA | Status: COMPLETED